176 related articles for article (PubMed ID: 2058083)
61. Classification of myeloproliferative disorders by bone marrow histology.
Frisch B; Bartl R; Burkhardt R; Jäger K; Mahl G; Kettner G
Bibl Haematol; 1984; (50):57-80. PubMed ID: 6590039
[No Abstract] [Full Text] [Related]
62. Circulating erythroid and megakaryocytic progenitors in polycythaemia vera and essential thrombocythaemia.
Florensa L; Besses C; Almarcha J; Lafuente R; Palou L; Pedro C; Sans-Sabrafen J; Woessner S
Eur J Haematol; 1989 Nov; 43(5):417-22. PubMed ID: 2693129
[TBL] [Abstract][Full Text] [Related]
63. Enzyme negative blastic transformation of chronic myeloproliferative disorders: immunophenotyping of the blastic cell population.
Matolcsy A; Izer I; Magyarlaki T; Baranyay F
Haematologia (Budap); 1991; 24(1):27-37. PubMed ID: 1813360
[TBL] [Abstract][Full Text] [Related]
64. [Molecular diagnosis of chronic myeloproliferative diseases and myelodysplastic syndromes].
Bock O
Verh Dtsch Ges Pathol; 2007; 91():140-53. PubMed ID: 18314608
[TBL] [Abstract][Full Text] [Related]
65. Bone marrow stromal cells in myeloproliferative disorders.
Hirata J; Takahira H; Kaneko S; Nishimura J; Nawata H
Acta Haematol; 1989; 82(1):35-9. PubMed ID: 2505472
[TBL] [Abstract][Full Text] [Related]
66. [Pathologic study on megakaryocytes in chronic myeloproliferative disorders].
Lin N; Liang P
Zhonghua Bing Li Xue Za Zhi; 1991 Jun; 20(2):113-5. PubMed ID: 1914016
[TBL] [Abstract][Full Text] [Related]
67. Histologic criteria for classification and differential diagnosis of chronic myeloproliferative disorders.
Frisch B; Bartl R; Burkhardt R; Jäger K
Haematologia (Budap); 1984; 17(2):209-26. PubMed ID: 6534829
[TBL] [Abstract][Full Text] [Related]
68. Osteoclasts and bone remodeling in chronic myeloproliferative disorders. A histochemical and morphometric study on trephine biopsies in 165 patients.
Thiele J; Hoeppner B; Wienhold S; Schneider G; Fischer R; Zankovich R
Pathol Res Pract; 1989 Jun; 184(6):591-9. PubMed ID: 2780431
[TBL] [Abstract][Full Text] [Related]
69. [Use of interferon in the treatment of chronic myeloproliferative disorders].
Robak T
Acta Haematol Pol; 1992; 23(2 Suppl 1):30-7. PubMed ID: 1488870
[TBL] [Abstract][Full Text] [Related]
70. [Chronic myeloproliferative diseases].
Sréter L
Orv Hetil; 1998 Jul; 139(30):1779-83. PubMed ID: 9718944
[TBL] [Abstract][Full Text] [Related]
71. Modern diagnostics in chronic myeloproliferative diseases (CMPDs).
Haferlach T; Kern W; Schnittger S; Schoch C
Ann Hematol; 2004; 83 Suppl 1():S59-61. PubMed ID: 15124674
[TBL] [Abstract][Full Text] [Related]
72. Clinical significance of serum soluble interleukin-2 receptor in chronic myeloproliferative disorders.
Kawatani T; Endo A; Tajima F; Ooi S; Kawasaki H
Int J Hematol; 1997 Feb; 65(2):123-8. PubMed ID: 9071816
[TBL] [Abstract][Full Text] [Related]
73. Transcription factor Fli-1 expression by bone marrow cells in chronic myeloproliferative disorders is independent of an underlying JAK2 (V617F) mutation.
Bock O; Hussein K; Neusch M; Schlué J; Wiese B; Kreipe H
Eur J Haematol; 2006 Dec; 77(6):463-70. PubMed ID: 16930139
[TBL] [Abstract][Full Text] [Related]
74. Plasma basic fibroblast growth factor and bone marrow fibrosis in clonal myeloproliferative disorders.
Sayinalp N; Cinar H; Uner A; Haznedaroğlu IC; Büyükaşik Y; Göker H; Aksu S; Ozcebe OI; Karakuş S; Kirazli S; Dündar SV
Clin Lab Haematol; 2004 Aug; 26(4):265-8. PubMed ID: 15279663
[TBL] [Abstract][Full Text] [Related]
75. A critical reappraisal of the WHO classification of the chronic myeloproliferative disorders.
Thiele J; Kvasnicka HM
Leuk Lymphoma; 2006 Mar; 47(3):381-96. PubMed ID: 16396760
[TBL] [Abstract][Full Text] [Related]
76. Megakaryocyte markers in myeloproliferative disorders.
Iványi JL; Kiss A; Telek B; Tornai I
Acta Histochem; 1993 Sep; 95(1):79-88. PubMed ID: 7506475
[TBL] [Abstract][Full Text] [Related]
77. Increased Dkk3 protein expression in platelets and megakaryocytes of patients with myeloproliferative neoplasms.
Medinger M; Tzankov A; Kern J; Pircher A; Hermann M; Ott HW; Gastl G; Untergasser G; Gunsilius E
Thromb Haemost; 2011 Jan; 105(1):72-80. PubMed ID: 20978717
[TBL] [Abstract][Full Text] [Related]
78. The myeloproliferative disorders. An historical appraisal and personal experiences.
Michiels JJ
Leuk Lymphoma; 1996 Sep; 22 Suppl 1():1-14. PubMed ID: 8951768
[TBL] [Abstract][Full Text] [Related]
79. The frequency and significance of megakaryocytic emperipolesis in myeloproliferative and reactive states.
Cashell AW; Buss DH
Ann Hematol; 1992 Jun; 64(6):273-6. PubMed ID: 1637881
[TBL] [Abstract][Full Text] [Related]
80. Human megakaryocytes. III. Characterization in myeloproliferative disorders.
Rabellino EM; Levene RB; Nachman RL; Leung LL
Blood; 1984 Mar; 63(3):615-22. PubMed ID: 6230121
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]